Ahmet Ufuk Kömüroğlu

Ahmet Ufuk Kömüroğlu

Auto-generated profile, based on publicly available information

Ahmet Ufuk Kömüroğlu

Van Yuzuncu Yil University, Vocational School of Health Services, 65080, Van, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
DDDuygu Doğan
Duygu Doğan
IMismet meydan
ismet meydan
AKAhmet Ufuk Kömüroğlu
Ahmet Ufuk Kömüroğlu
Objective. This study aimed to investigate the effects of gallic acid and silymarin against nephrotoxicity and hepatotoxicity caused by cisplatin. Materials and Methods. In the study, 56 Wistar Albino rats were equally divided into eight groups. Group 1 was the control group; group 2 was the group receiving cisplatin; group 3 was the group receiving cisplatin + gallic acid; group 4 was the group receiving cisplatin + silymarin; group 5 was the group receiving cisplatin + silymarin + gallic acid; group 6 was the group receiving silymarin; group 7 was the group receiving gallic acid; group 8 was the group receiving gallic acid + silymarin. AST, ALT, urea, creatinine, albumin, globulin, and total protein levels were measured at the end of the study. Superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), glutathione (GSH), and 8‐hydroxy‐2′‐deoxyguanosine (8OH‐dG) levels were measured in kidney and liver tissues. Additionally, histopathological evaluations of the tissues were also performed. Results. In kidney and liver tissues, cisplatin significantly increased MDA and 8‐OHdG levels compared with treatment groups (p < 0.05). Silymarin‐treated group significantly increased the SOD activity and GSH amount in the liver tissue compared with the cisplatin‐treated group (p < 0.05). Gallic acid significantly increased CAT activity compared with the cisplatin‐treated group (p < 0.05). It was determined that the cisplatin‐treated group significantly decreased CAT and SOD activity compared with the control group (p > 0.05). Gallic acid showed a significant increase in CAT and SOD activity in kidney tissue compared with the cisplatin‐treated group (p < 0.05). Conclusion. As a result, it was observed that gallic acid silymarin had a protective effect on cisplatin‐induced nephrotoxic and hepatotoxic effects.


23 October 2020 in Journal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie
Verified
Journal Article
Closed access
PDF file
YKYeşim KAYA
Yeşim KAYA
ÖAÖzer Alkan
Özer Alkan
AKAhmet Ufuk Kömüroglu
Ahmet Ufuk Kömüroglu
SKSıddık Keskin
Sıddık Keskin

16 July 2020 in Andrologia
Verified
Journal Article
Closed access
PDF file
SBSaadet Belhan
Saadet Belhan
MÖMustafa Özkaraca
Mustafa Özkaraca
UÖUğur Özdek
Uğur Özdek
AKAhmet Ufuk Kömüroğlu
Ahmet Ufuk Kömüroğlu

1 February 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
OEOzlem Ergul Erkec
Ozlem Ergul Erkec
AMAysel Milanlıoğlu
Aysel Milanlıoğlu
AKAhmet Ufuk Komuroglu
Ahmet Ufuk Komuroglu
MKMehmet Kara
Mehmet Kara
ZHZübeyir Huyut
Zübeyir Huyut
SKSıddık Keskin
Sıddık Keskin
Epilepsy is a common disorder that affects the nervous systems of 1% of worldwide population. In epilepsy, one-third of patients are unresponsive to current drug therapies and develop drug-resistant epilepsy. Alterations in ghrelin, nesfatin-1, and irisin levels with epilepsy were reported in previous studies. Vasoactive intestinal peptide is among the most common neuropeptides in the hippocampus, which is the focus of the seizures in temporal lobe epilepsy. However, there is also lack of evidence of whether these four neuropeptide levels are altered with drug resistant temporal lobe epilepsy or not. The aim herein was the evaluation of the serum levels of nesfatin-1, ghrelin, irisin, and Vasoactive intestinal peptide in drug-resistant temporal lobe epilepsy patients and temporal lobe epilepsy (TLE) without drug resistance, and to compare them to healthy controls. This cross-sectional study group included 58 temporal lobe epilepsy patients (24 with drug resistant temporal lobe epilepsy and 34 with temporal lobe epilepsy who were not drug-resistant) and 28 healthy subjects. Nesfatin-1, ghrelin, irisin, and Vasoactive intestinal peptide serum levels were determined using enzyme-linked immunosorbent assay. The serum ghrelin levels of patients with drug resistant temporal lobe epilepsy were seen to have significantly decreased when compared to those of the control group (p0.05). The results herein suggested that ghrelin might contribute to the pathophysiology of drug resistant temporal lobe epilepsy. However, further studies are needed to confirm this hypothesis.

17 November 2021 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
AKAhmet Ufuk Komuroglu
Ahmet Ufuk Komuroglu
HSHamdullah SEÇKİN
Hamdullah SEÇKİN
MEMetin Ertaş
Metin Ertaş
IMismet meydan
ismet meydan